XRAY vs HSIC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

XRAY

52.3
AI Score
VS
XRAY Wins

HSIC

51.9
AI Score

Investment Advisor Scores

XRAY

52score
Recommendation
HOLD

HSIC

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY HSIC Winner
Forward P/E 10.0705 16.0514 XRAY
PEG Ratio 0.7521 1.841 XRAY
Revenue Growth 0.1% 6.3% HSIC
Earnings Growth 15.2% 4.5% XRAY
Tradestie Score 52.3/100 51.9/100 XRAY
Profit Margin -17.1% 2.9% HSIC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: +20.6% · 3M: +13.8% HSIC 1M: +1.5% · 3M: +15.0%

Current Technical Phase

XRAY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 58

RSI (14): 57.8 · Price: $13.37

HSIC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 55

RSI (14): 55.4 · Price: $85.75

Fundamentals Snapshot

Metric XRAY HSIC
Market Cap
Forward P/E 8.6 14.5
Trailing P/E 25.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.0% 0.1%
EPS -3.05 3.29
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.